Transcatheter aorticvalve replacement (TAVR) outcomes in patients with thrombocytopenia: Insights from the national inpatient sample 2016-2019

Authors

Omar Tayseer Al Ali, Rochester Regional HealthFollow
Ali Abdelhay, Rochester Regional HealthFollow
Mohamed Salah Mohamed, Rochester Regional HealthFollow
Anas M. Hashem, Rochester Regional HealthFollow
Salman Zahid, Rochester Regional HealthFollow
Sheref Elseidy, Rochester Regional HealthFollow
Mohamed Eid, Rochester Regional HealthFollow

Department

Medicine

Document Type

Conference Proceeding

Publication Title

Journal of the American College of Cardiology

Conference Name

ACC.23

Conference Date

2023-03-04 - 2023-03-06

First Page

1075

DOI

10.1016/S0735-1097(23)01519-X

Volume

81

Issue

8 Supplement

Publication Date

3-7-2023

Recommended Citation

Al Ali, O. T., Abdelhay, A., Mohamed, M. S., Hashem, A. M., Zahid, S., Elseidy, S., & Eid, M. (2023). Transcatheter aorticvalve replacement (TAVR) outcomes in patients with thrombocytopenia: Insights from the national inpatient sample 2016-2019. Journal of the American College of Cardiology, 81 (8 Supplement), 1075. https://doi.org/10.1016/S0735-1097(23)01519-X